B BRAUN 0.9% SODIUM CHLORIDE AND GLUCOSE 5% 1000mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 0.9% sodium chloride and glucose 5% 1000ml injection

b braun australia pty ltd - sodium chloride, quantity: 9 g/l; glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as solvent for intravenously administered drugs where compatibility has been established.

B BRAUN 0.9% SODIUM CHLORIDE AND GLUCOSE 5% 500mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

b braun 0.9% sodium chloride and glucose 5% 500ml injection

b braun australia pty ltd - sodium chloride, quantity: 9 g/l; glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solution may also be used as solvent for intravenously administered drugs where compatibility has been established.

ROPIVACAINE SANDOZ ropivacaine hydrochloride (as monohydrate) 200mg/100mL solution for injection infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 200mg/100ml solution for injection infusion bag

sandoz pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

ROPIVACAINE SANDOZ ropivacaine hydrochloride (as monohydrate) 100mg/20mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 100mg/20ml solution for injection ampoule

sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

ROPIVACAINE SANDOZ ropivacaine hydrochloride (as monohydrate) 50mg/10mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 50mg/10ml solution for injection ampoule

sandoz pty ltd - ropivacaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.15% w/v and sodium chloride 0.9% w/v solution for infusion

b. braun melsungen ag - potassium chloride; sodium chloride - solution for infusion - 0.15%w/ +0.9 percent weight/volume - solutions affecting the electrolyte balance; electrolytes

Compound Sodium Lactate Intravenous Infusion BP, Ecobag (Hartmann’s Solution) Ireland - English - HPRA (Health Products Regulatory Authority)

compound sodium lactate intravenous infusion bp, ecobag (hartmann’s solution)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - per cent - solutions affecting the electrolyte balance; electrolytes

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium chloride 0.3% w/v and sodium chloride 0.9% w/v solution for infusion

b. braun melsungen ag - potassium chloride; sodium chloride - solution for infusion - 0.3%w/ + 0.9 percent weight/volume - solutions affecting the electrolyte balance; electrolytes

NaCl 0,9 % B. Braun inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nacl 0,9 % b. braun inf. sol. i.v. vial

b. braun melsungen ag - sodium chloride 0,9 g/100 ml - solution for infusion - sodium chloride 9 mg/g - solvents and diluting agents, incl. irrigating solutions

NaCl 0,9 % B. Braun inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nacl 0,9 % b. braun inf. sol. i.v. vial

b. braun melsungen ag - sodium chloride 9 g/1000 ml - solution for infusion - sodium chloride 9 mg/g - solvents and diluting agents, incl. irrigating solutions